학술논문
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis
Document Type
Article
Author
Source
In Cancer Treatment and Research Communications 2021 27
Subject
Language
ISSN
2468-2942